Expression of miR-23a was shown to inhibit cytotoxic CD8 T cell-mediated antitumor responses in a mouse model of melanoma by directly targeting the transcription factor Blimp-1 and downstream effector molecules granzyme B, T-bet and IFN-γ [64]. The gene discussed is CD8A; the disease is melanoma.